Trade Mark Journal No.2026/009 27 February 2026
WO0000001900926 (9,42)
Office of origin: United States of America
Date of International Registration:10 December 2025
Date of designation in the UK:
10 December 2025
International priority date claimed: 9 September 2025
(United States of America)
(99382623)
- Class 9
- Downloadable software for use in statistical analysis and forecasting for use in planning, implementing and monitoring clinical trials and user manuals sold together therewith.
- Class 42
- Providing temporary use of non-downloadable cloud-based software for use in statistical analysis and forecasting for the planning, implementing, and monitoring of clinical trials and/or the creation and implementation of formulated decision guidelines for use in clinical development; providing temporary use of non-downloadable cloud-based software for the creation and implementation of formulated decision guidelines for use in clinical development; software as a service (SaaS) services featuring software for use by product development teams at pharmaceutical and biotech companies, nonprofit, government or academic institutions, and others to forecast patient enrollment in clinical trials and communicate recommendations to decision makers; platform as a service (PaaS) featuring computer software platforms for use by product development teams at pharmaceutical and biotech companies to plan and monitor clinical trials and communicate recommendations to management and governance boards.
Cytel Inc.
Representative: Sean D. Detweiler Morse, Barnes-Brown & Pendleton, P.C., 480 Totten Pond Road, 4th Floor, CityPoint, Waltham MA 02451, UNITED STATES OF AMERICA